Articles

Results 1 to 5 of 51
Most popular |Most recent


Federal Circuit Simplifies BPCIA Disputes by Finding State Remedies Preempted

USA - December 20 2017 The Amgen v. Sandoz battle continues to make new law regarding the Biologics Price Competition and Innovation Act ("BPCIA"), this time in a December…

Tasha M. Francis.

The Herceptin® Battle Moves into the District Court

USA - November 22 2017 On November 17, 2017, Genentech filed suit against Pfizer in the District of Delaware, alleging that Pfizer's biosimilar of Herceptin® infringes…

Casey Kraning-Rush, Tasha M. Francis.

Federal Circuit Provides Guidance on Probative Value of “Patent Dance” Letters and aBLA Parameters in an Infringement Analysis

USA - November 15 2017 On November 13th, in an opinion drafted by Judge Taranto, the Federal Circuit affirmed the Southern District Court of Florida's judgment that Apotex's…

Tasha M. Francis.

List it or Lose it: The Federal Circuit Weighs in on the Amgen v. Hospira Discovery Dispute

USA - August 11 2017 The Federal Circuit issued its opinion in the Amgen v. Hospira appeal (16-2179) on August 10, 2017, dismissing the appeal for lack of jurisdiction and…

The Ramifications of Leaving the Patent Dance Floor

USA - August 3 2017 While the Supreme Court held in Amgen v. Sandoz that biosimilar applicants cannot be forced with a federal injunction to provide a copy of their…

Tasha M. Francis.